AI Dermatology Tools for Melanoma Detection in Primary Care
Early detection tools could narrow racial disparities in melanoma survival rates.
Ruth Bennett
Section
8 stories in AI Medical Diagnostics.
Early detection tools could narrow racial disparities in melanoma survival rates.
Early alerts cut sepsis deaths when AI models are carefully validated.
Regulators demand rigorous clinical evidence before approving AI diagnostic tools.
Models trained on skewed datasets underdiagnose patients from underrepresented groups at scale.
AI dominates narrow, pattern-heavy tasks but loses ground fast when cases get messy or ambiguous.
Radiology dominates FDA-cleared AI approvals, but clearance means safety review, not clinical proof.
Hospitals need a framework for evaluating AI tools that evolve after purchase.
Doctors must explain how AI contributed to a diagnosis, not just the result itself.